Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot Q13950 (RUNX2_HUMAN)

Last modified November 25, 2008. Version 84. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Runt-related transcription factor 2
Alternative name(s):
    Core-binding factor subunit alpha-1
      Short name=CBF-alpha-1
    Acute myeloid leukemia 3 protein
    Oncogene AML-3
    Polyomavirus enhancer-binding protein 2 alpha A subunit
      Short name=PEBP2-alpha A
      Short name=PEA2-alpha A
    SL3-3 enhancer factor 1 alpha A subunit
    SL3/AKV core-binding factor alpha A subunit
    Osteoblast-specific transcription factor 2
      Short name=OSF-2
Gene names
Name: RUNX2
Synonyms: AML3, CBFA1, OSF2, PEBP2A
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length521 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters By similarity. Inhibits MYST4-dependent transcriptional activation.

Subunit structure

Heterodimer of an alpha and a beta subunit. Interacts with HIVEP3 By similarity. The alpha subunit binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Interacts with G22P1 (Ku70) and XRCC5 (Ku80). Interacts with MYST3 and MYST4.

Subcellular location

Nucleus.

Tissue specificity

Specifically expressed in osteoblasts.

Domain

A proline/serine/threonine rich region at the C-terminus is necessary for transcriptional activation of target genes and contains the phosphorylation sites.

Post-translational modification

Phosphorylated; probably by MAP kinases (MAPK) By similarity. Isoform 3 is phosphorylated on Ser-340.

Involvement in disease

Defects in RUNX2 are the cause of cleidocranial dysplasia (CCD) [MIM:119600]. CCD is an autosomal dominant skeletal disorder with high penetrance and variable expressivity. It is due to defective endochondral and intramembranous bone formation. Typical features include hypoplasia/aplasia of clavicles, patent fontanelles, wormian bones (additional cranial plates caused by abnormal ossification of the calvaria), supernumerary teeth, short stature, and other skeletal changes. In some cases defects in RUNX2 are exclusively associated with dental anomalies.

Sequence similarities

Contains 1 Runt domain.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

SMAD6O435412EBI-976402,EBI-976374
SMURF1Q9HCE71EBI-976402,EBI-976466

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q13950-1)

Also known as: Cbfa1a;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q13950-2)

The sequence of this isoform differs from the canonical sequence as follows:
     1-19: MASNSLFSTVTPCQQNFFW → MRIPV
Isoform 3 (identifier: Q13950-3)

Also known as: Cbfa1b;

The sequence of this isoform differs from the canonical sequence as follows:
     341-362: Missing.
Notes: Phosphorylated on Ser-340.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 521521Runt-related transcription factor 2
PRO_0000174659

Regions

Domain101 – 229129Runt
Region336 – 439104Interaction with MYST3 By similarity
Region374 – 46895Interaction with MYST4
Compositional bias49 – 7123Poly-Gln
Compositional bias73 – 8917Poly-Ala
Compositional bias237 – 521285Pro/Ser/Thr-rich

Natural variations

Alternative sequence1 – 1919MASNS…QNFFW → MRIPV in isoform 2.
VSP_005937
Alternative sequence341 – 36222Missing in isoform 3.
VSP_005938
Natural variant78 – 836Missing
VAR_012131
Natural variant841A → AAAAAAAAAAA in CCD associated with brachydactyly of hands and feet.
VAR_012130
Natural variant1131L → R in CCD.
VAR_012132
Natural variant1181S → R in CCD.
VAR_012133
Natural variant1211F → C in CCD.
VAR_012134
Natural variant1231C → R in CCD.
VAR_012135
Natural variant1331Missing in CCD.
VAR_012136
Natural variant1691R → Q in CCD.
VAR_012137
Natural variant1751M → R in CCD; abolishes DNA binding.
VAR_012138
Natural variant1901R → Q in CCD; abolishes DNA binding.
VAR_012139
Natural variant1901R → W in CCD.
VAR_012140
Natural variant1911S → N in CCD; abolishes DNA binding.
VAR_012141
Natural variant1931R → C in CCD.
VAR_012142
Natural variant1971F → S in CCD; abolishes DNA binding.
VAR_012143
Natural variant1991L → F in CCD; abolishes DNA binding.
VAR_012144
Natural variant2001T → A in CCD; mild; associated also with isolated dental anomalies; normal DNA binding.
VAR_012145
Natural variant2051T → R in CCD.
VAR_012146
Natural variant2091Q → R in CCD.
VAR_012147
Natural variant2251R → Q in CCD; interferes with nuclear localization; abolishes DNA binding.
VAR_012148
Natural variant2251R → W in CCD; interferes with nuclear localization.
VAR_012149
Natural variant5111G → S in CCD; could be a polymorphism.
VAR_012150

Experimental info

Sequence conflict161N → S in AAC77441. Ref.4

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 (Cbfa1a) [UniParc].

Last modified November 2, 2001. Version 2.
Checksum: 44C4F3867D6F3EB1

FASTA52156,648
        10         20         30         40         50         60 
MASNSLFSTV TPCQQNFFWD PSTSRRFSPP SSSLQPGKMS DVSPVVAAQQ QQQQQQQQQQ 

        70         80         90        100        110        120 
QQQQQQQQQQ QEAAAAAAAA AAAAAAAAAV PRLRPPHDNR TMVEIIADHP AELVRTDSPN 

       130        140        150        160        170        180 
FLCSVLPSHW RCNKTLPVAF KVVALGEVPD GTVVTVMAGN DENYSAELRN ASAVMKNQVA 

       190        200        210        220        230        240 
RFNDLRFVGR SGRGKSFTLT ITVFTNPPQV ATYHRAIKVT VDGPREPRRH RQKLDDSKPS 

       250        260        270        280        290        300 
LFSDRLSDLG RIPHPSMRVG VPPQNPRPSL NSAPSPFNPQ GQSQITDPRQ AQSSPPWSYD 

       310        320        330        340        350        360 
QSYPSYLSQM TSPSIHSTTP LSSTRGTGLP AITDVPRRIS DDDTATSDFC LWPSTLSKKS 

       370        380        390        400        410        420 
QAGASELGPF SDPRQFPSIS SLTESRFSNP RMHYPATFTY TPPVTSGMSL GMSATTHYHT 

       430        440        450        460        470        480 
YLPPPYPGSS QSQSGPFQTS STPYLYYGTS SGSYQFPMVP GGDRSPSRML PPCTTTSNGS 

       490        500        510        520 
TLLNPNLPNQ NDGVDADGSH SSSPTVLNSS GRMDESVWRP Y 

« Hide

Isoform 2 [UniParc].

Checksum: 7228C267328DE1DC
Show »

50755,054
Isoform 3 (Cbfa1b) [UniParc].

Checksum: 4BA956230C96EB2E
Show »

49954,249

References

« Hide 'large scale' references
[1]"Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia."
Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H.M., Owen M.J., Mertelsmann R., Zabel B.U., Olsen B.R.
Cell 89:773-779(1997) [PubMed: 9182765] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), VARIANT CCD ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-84 INS, VARIANT 78-ALA--ALA-83 DEL.
[2]"Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function."
Geoffroy V., Corral D.A., Zhou L., Lee B., Karsenty G.
Mamm. Genome 9:54-57(1998) [PubMed: 9434946] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 3), ALTERNATIVE SPLICING.
[3]"The DNA sequence and analysis of human chromosome 6."
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. expand/collapse author list , Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.
Nature 425:805-811(2003) [PubMed: 14574404] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[4]"Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor."
Xiao Z.S., Thomas R., Hinson T.K., Quarles L.D.
Gene 214:187-197(1998) [PubMed: 9651525] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-19 (ISOFORM 1).
[5]"The cDNA cloning of the transcripts of human PEBP2alphaA/CBFA1 mapped to 6p12.3-p21.1, the locus for cleidocranial dysplasia."
Zhang Y.-W., Bae S.-C., Takahashi E., Ito Y.
Oncogene 15:367-371(1997) [PubMed: 9233771] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE OF 60-521 (ISOFORM 3).
[6]"Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex."
Willis D.M., Loewy A.P., Charlton-Kachigian N., Shao J.-S., Ornitz D.M., Towler D.A.
J. Biol. Chem. 277:37280-37291(2002) [PubMed: 12145306] [Abstract]
Cited for: INTERACTION WITH G22P1 AND XRCC5.
Tissue: Osteoblast.
[7]"MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2."
Pelletier N., Champagne N., Stifani S., Yang X.-J.
Oncogene 21:2729-2740(2002) [PubMed: 11965546] [Abstract]
Cited for: INTERACTION WITH MYST3 AND MYST4, FUNCTION.
[8]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340 (ISOFORM 3), MASS SPECTROMETRY.
[9]"Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia."
Lee B., Thirunavukkarasu K., Zhou L., Pastore L., Baldini A., Hecht J., Geoffroy V., Ducy P., Karsenty G.
Nat. Genet. 16:307-310(1997) [PubMed: 9207800] [Abstract]
Cited for: VARIANTS CCD ARG-175 AND ASN-191.
[10]"Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia."
Quack I., Vonderstrass B., Stock M., Aylsworth A.S., Becker A., Brueton L., Lee P.J., Majewski F., Mulliken J.B., Suri M., Zenker M., Mundlos S., Otto F.
Am. J. Hum. Genet. 65:1268-1278(1999) [PubMed: 10521292] [Abstract]
Cited for: VARIANTS CCD ARG-113; ARG-118; CYS-121; ARG-123; ARG-205; GLN-225; TRP-225 AND SER-511.
[11]"CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia."
Zhou G., Chen Y., Zhou L., Thirunavukkarasu K., Hecht J., Chitayat D., Gelb B.D., Pirinen S., Berry S.A., Greenberg C.R., Karsenty G., Lee B.
Hum. Mol. Genet. 8:2311-2316(1999) [PubMed: 10545612] [Abstract]
Cited for: VARIANTS CCD ASN-133 DEL; GLN-169; ARG-175; GLN-190; ASN-191; CYS-193; PHE-199; ALA-200; ARG-209 AND GLN-225.
[12]"PEBP2alphaA/CBFA1 mutations in Japanese cleidocranial dysplasia patients."
Zhang Y.-W., Yasui N., Kakazu N., Abe T., Takada K., Imai S., Sato M., Nomura S., Ochi T., Okuzumi S., Nogami H., Nagai T., Ohashi H., Ito Y.
Gene 244:21-28(2000) [PubMed: 10689183] [Abstract]
Cited for: VARIANT CCD SER-197.
[13]"A novel CBFA1 mutation (R190W) in an Italian family with cleidocranial dysplasia."
Giannotti A., Tessa A., Patrono C., De Florio L., Velardo M., Dionisi-Vici C., Bertini E., Santorelli F.M.
Hum. Mutat. 16:277-277(2000) [PubMed: 10980549] [Abstract]
Cited for: VARIANT CCD TRP-190.
+Additional computationally mapped references.

Cross-references

Sequence databases

AF001450 expand/collapse EMBL AC list , AF001443, AF001444, AF001445, AF001446, AF001447, AF001448, AF001449 Genomic DNA. Translation: AAB65159.2.
AF001450 expand/collapse EMBL AC list , AF001444, AF001445, AF001446, AF001447, AF001448, AF001449 Genomic DNA. Translation: AAB65158.1.
AL161907, AL096865, AL358135 Genomic DNA. Translation: CAI19638.1.
AL161907, AL096865, AL358135 Genomic DNA. Translation: CAI19639.1.
AL358135, AL096865, AL161907 Genomic DNA. Translation: CAI13528.1.
AL358135, AL096865, AL161907 Genomic DNA. Translation: CAI13531.1.
AL096865, AL161907, AL358135 Genomic DNA. Translation: CAI19925.1.
AL096865, AL161907, AL358135 Genomic DNA. Translation: CAI19931.1.
AF053952 mRNA. Translation: AAC78624.1.
AF053949 Genomic DNA. Translation: AAC77441.1.
L40992 mRNA. Translation: AAA89072.1.
RefSeqNP_001015051.2.
NP_001019801.2.
NP_004339.3.
UniGeneHs.535845

3D structure databases

HSSPHSSP built from PDB template 1HJB based on UniProtKB Q03347.
SMRQ13950. Positions 105-229.
ModBase